Mumbai: Woman Held For Selling Fake Cancer Drugs

Mumbai : The Crime Branch (CB) Control on Thursday arrested a 30-year-old woman from Kalyan for selling spurious medicines in the name of genuine Adcetris injection and Iclusig tablet used in cancer patients’ treatment.

The value of the spurious medicines is estimated to be over Rs 67 lakh. The genuine medicines are manufactured by a Japanese company whose representative lodged a police complaint.

The accused, Pooja Rana, owns Prime Pharma, a pharmaceutical company located in Kalyan. She was produced before a court on Friday and remanded in police custody till October 4.

Inspector Nitin Patil of the CB Control, a unit of the city Economic Offences Wing, said, “The Japanese company has appointed an Indian firm to take legal action if they find intellectual property rights violations concerninh their products. We were informed about the sale of these fake products in March. A trap was laid and one Adcetris injection was purchased for Rs.1.12 lakh in Santacruz through Prime Pharma. The seized product was sent for forensic analysis, and the report stated that it was fake and was not manufactured by the Japanese company concerned,” said a police source. The actual price of a genuine injection is Rs 5.80 lakh.

Based on the forensic report, a case was registered under various sections of the IPC and Copyright Act at the Santacruz police station on Thursday and the probe was transferred to the EOW.

A police team arrived at Prime Pharma’s office in Kalyan and during search it seized six fake Adcetris injections and two Iclusig tablets. Rana was arrested.

“These medicines are not manufactured in India, and can be imported only through a proper licence. The accused was was selling such spurious medicines which could harm human lives,” said Niket Kaushik, EOW chief.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 64 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 93 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt